Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.85 USD | +2.06% | +2.48% | -27.84% |
Apr. 15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.84% | 1.49B | |
-15.64% | 11.33B | |
+39.24% | 3.16B | |
-18.79% | 2.04B | |
-34.97% | 2.14B | |
+12.52% | 975M | |
-4.37% | 731M | |
-48.78% | 364M | |
+26.64% | 371M | |
+27.51% | 245M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Scotiabank Initiates Veracyte at Sector Outperform With $33 Price Target